284 related articles for article (PubMed ID: 11031222)
1. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression.
Lindmark E; Tenno T; Siegbahn A
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2322-8. PubMed ID: 11031222
[TBL] [Abstract][Full Text] [Related]
2. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist.
Zhao L; Bath PM; May J; Lösche W; Heptinstall S
Platelets; 2003; 14(7-8):473-80. PubMed ID: 14713516
[TBL] [Abstract][Full Text] [Related]
3. Platelet-CD40 ligand interaction with melanoma cell and monocyte CD40 enhances cellular procoagulant activity.
Amirkhosravi A; Amaya M; Desai H; Francis JL
Blood Coagul Fibrinolysis; 2002 Sep; 13(6):505-12. PubMed ID: 12192302
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor and IL8 production by P-selectin-dependent platelet-monocyte aggregates in whole blood involves phosphorylation of Lyn and is inhibited by IL10.
Christersson C; Johnell M; Siegbahn A
J Thromb Haemost; 2008 Jun; 6(6):986-94. PubMed ID: 18363812
[TBL] [Abstract][Full Text] [Related]
5. Platelet P-selectin triggers rapid surface exposure of tissue factor in monocytes.
Ivanov II; Apta BHR; Bonna AM; Harper MT
Sci Rep; 2019 Sep; 9(1):13397. PubMed ID: 31527604
[TBL] [Abstract][Full Text] [Related]
6. Effect of glycoprotein IIb/IIIa antagonist abciximab on monocyte-platelet aggregates and tissue factor expression.
Steiner S; Seidinger D; Huber K; Kaun C; Minar E; Kopp CW
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1697-702. PubMed ID: 12869353
[TBL] [Abstract][Full Text] [Related]
7. Effects of alimentary lipemia and inflammation on platelet CD40-ligand.
Kälsch T; Elmas E; Nguyen XD; Kralev S; Leweling H; Klüter H; Dempfle CE; Borggrefe M
Thromb Res; 2007; 120(5):703-8. PubMed ID: 17289125
[TBL] [Abstract][Full Text] [Related]
8. Endotoxin-induced effects on platelets and monocytes in an in vivo model of inflammation.
Kälsch T; Elmas E; Nguyen XD; Suvajac N; Klüter H; Borggrefe M; Dempfle CE
Basic Res Cardiol; 2007 Sep; 102(5):460-6. PubMed ID: 17624488
[TBL] [Abstract][Full Text] [Related]
9. [Effect of platelet on procoagulant activity of monocyte].
Xu J; He X; Xiong S
Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):478-80. PubMed ID: 11758230
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
Schmidt R; Bültmann A; Fischel S; Gillitzer A; Cullen P; Walch A; Jost P; Ungerer M; Tolley ND; Lindemann S; Gawaz M; Schömig A; May AE
Circ Res; 2008 Feb; 102(3):302-9. PubMed ID: 18048771
[TBL] [Abstract][Full Text] [Related]
11. Human platelets do not express tissue factor.
Østerud B; Olsen JO
Thromb Res; 2013 Jul; 132(1):112-5. PubMed ID: 23623171
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein.
Boden G; Vaidyula V; Homko C; Mozzoli M; Rao AK
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1333-9. PubMed ID: 17213471
[TBL] [Abstract][Full Text] [Related]
13. The role of platelets in decrypting monocyte tissue factor.
Østerud B
Dis Mon; 2003 Jan; 49(1):7-13. PubMed ID: 12525824
[TBL] [Abstract][Full Text] [Related]
14. Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes.
del Conde I; Nabi F; Tonda R; Thiagarajan P; López JA; Kleiman NS
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1065-70. PubMed ID: 15705928
[TBL] [Abstract][Full Text] [Related]
15. Platelet-induced expression of tissue factor procoagulant activity in freshly isolated human mononuclear cells: implications for experimental use.
Meisel SR; Shechter M; Xu XP; Edgington TS; Cercek B; Shah PK
Clin Lab Haematol; 2003 Oct; 25(5):321-5. PubMed ID: 12974724
[TBL] [Abstract][Full Text] [Related]
16. Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells.
May AE; Kälsch T; Massberg S; Herouy Y; Schmidt R; Gawaz M
Circulation; 2002 Oct; 106(16):2111-7. PubMed ID: 12379582
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of agonist-induced p42 and p38 mitogen-activated protein kinase phosphorylation and CD40 ligand/P-selectin expression by cyclic nucleotide-regulated pathways in human platelets.
Schwarz UR; Kobsar AL; Koksch M; Walter U; Eigenthaler M
Biochem Pharmacol; 2000 Nov; 60(9):1399-407. PubMed ID: 11008134
[TBL] [Abstract][Full Text] [Related]
18. Regulation of CD40L (CD154) and CD62P (p-selectin) surface expression upon GPIIb-IIIa blockade of platelets from stable coronary artery disease patients.
Chandler AB; Earhart AD; Speich HE; Kueter TJ; Hansen J; White MM; Jennings LK
Thromb Res; 2010 Jan; 125(1):44-52. PubMed ID: 19487018
[TBL] [Abstract][Full Text] [Related]
19. Estrogenic regulation of tissue factor and tissue factor pathway inhibitor in platelets.
Jayachandran M; Sanzo A; Owen WG; Miller VM
Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H1908-16. PubMed ID: 15964915
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin and atorvastatin attenuate VCAM-1 and uPAR expression on human endothelial cells and platelet surface expression of CD40 ligand.
Stach K; Nguyen XD; Lang S; Elmas E; Weiss C; Borggrefe M; Fischer J; Kälsch T
Cardiol J; 2012; 19(1):20-8. PubMed ID: 22298164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
